Kolebanie urovnya serologicheskogo opukholeassotsiirovannogo markera SCC u bol'noy ploskokletochnym rakom sheyki matki v dlitel'noy remissii

The paper describes a follow-up of a patient with cancer of the cervix uteri (CCU) in remission. The serum level of SCC (the major tumor-associated marker of CCU) was determined 22 times in the patient. There were cases of lower and higher SCC levels, without achieving the upper normal range for this marker. At the same times, 2 successive measures showed increased SCC levels that were not confirmed by the development of a relapse of the underlying disease and the level of SCC was decreased. With the increased levels of SCC that do not exceed its upper normal range, analysis should be twice made at a 3-4-week interval. The assumption that there is a high probability of developing a recurrence is substantiated in cases of 3 successive SCC increases provided that the last value of the marker exceeds the upper normal range.

squamous cell carcinoma of the cervix uteri, tumor-associated marker SCC